Ensign Peak Advisors’s Kiniksa Pharmaceuticals KNSA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-66,443
| Closed | -$1.17M | – | 1735 |
|
|
2023
Q4 | $1.17M | Hold |
66,443
| – | – | ﹤0.01% | 1254 |
|
|
2023
Q3 | $1.15M | Hold |
66,443
| – | – | ﹤0.01% | 1085 |
|
|
2023
Q2 | $936K | Hold |
66,443
| – | – | ﹤0.01% | 1318 |
|
|
2023
Q1 | $715K | Hold |
66,443
| – | – | ﹤0.01% | 1496 |
|
|
2022
Q4 | $995K | Sell |
66,443
-11,310
| -15% | -$169K | ﹤0.01% | 1165 |
|
|
2022
Q3 | $998K | Buy |
77,753
+26,959
| +53% | +$346K | ﹤0.01% | 1064 |
|
|
2022
Q2 | $492K | Sell |
50,794
-1,946
| -4% | -$18.8K | ﹤0.01% | 1469 |
|
|
2022
Q1 | $524K | Hold |
52,740
| – | – | ﹤0.01% | 1537 |
|
|
2021
Q4 | $621K | Sell |
52,740
-21,073
| -29% | -$248K | ﹤0.01% | 1532 |
|
|
2021
Q3 | $841K | Buy |
73,813
+20,688
| +39% | +$236K | ﹤0.01% | 1491 |
|
|
2021
Q2 | $740K | Hold |
53,125
| – | – | ﹤0.01% | 1514 |
|
|
2021
Q1 | $983K | Hold |
53,125
| – | – | ﹤0.01% | 1430 |
|
|
2020
Q4 | $939K | Buy |
53,125
+26,916
| +103% | +$476K | ﹤0.01% | 1423 |
|
|
2020
Q3 | $402K | Buy |
26,209
+17,857
| +214% | +$274K | ﹤0.01% | 1582 |
|
|
2020
Q2 | $213K | Buy |
+8,352
| New | +$213K | ﹤0.01% | 1572 |
|